Tuesday’s Highlights at Noon: Cannabis Science Inc (CBIS), Growlife Inc (PHOT), JC Penney (JCP), Calumet Specialty Products (CLMT), CVR Refining (CVRR)

By Carrie Williams

So far Tuesday, December 26, NASDAQ is down -0.68% and the S&P is up 0.05%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Cannabis Science Inc (Other OTC:CBIS), Growlife Inc (Other OTC:PHOT), JC Penney (NYSE:JCP), Calumet Specialty Products (NASDAQ:CLMT) and CVR Refining (NYSE:CVRR).

Cannabis Science Inc is up 14.14% in midday trading to $0.08. Shares opened today at $0.07. The company has a 52-week low of $0.03 and a 52-week high of $0.14. In the last 30 days, insiders have sold $9,941 worth of CBIS shares.

Growlife Inc is up 12.82% in midday trading to $0.02. Shares opened today at $0.02. The company has a 52-week low of $0.00 and a 52-week high of $0.02.

JC Penney is up 8.1% in midday trading to $3.41. Shares opened today at $3.15. The company has a 52-week low of $2.35 and a 52-week high of $8.80. On the Street’s front, the average 12-month analyst price target for the stock is $3.03, marking a -3.81% potential downside from current levels. In a report issued on November 30, Cowen analyst Oliver Chen maintained a Hold rating on JCP, with a price target of $4, which represents a potential upside of 27% from where the stock is currently trading. Separately, on November 13, Citigroup’s Paul Lejuez maintained a Sell rating on the stock and has a price target of $1.50. In the last 30 days, insiders have sold $20.6K worth of JCP shares.

Calumet Specialty Products is up 7.02% in midday trading to $9.15. Shares opened today at $8.55. The company has a 52-week low of $3.40 and a 52-week high of $9.95. On the Street’s front, the average 12-month analyst price target for the stock is $7.5, marking a -12.28% potential downside from current levels. In a report issued on October 17, Cowen analyst Sam Margolin reiterated a Hold rating on CLMT, with a price target of $5, which implies a downside of 42% from current levels. Separately, on October 2, Wells Fargo’s Roger Read maintained a Buy rating on the stock and has a price target of $10.

CVR Refining is up 6.58% in midday trading to $16.20. Shares opened today at $15.20. The company has a 52-week low of $6.70 and a 52-week high of $16.42. On the Street’s front, the average 12-month analyst price target for the stock is $12.25, marking a -19.41% potential downside from current levels. In a report issued on November 15, UBS analyst Spiro M. Dounis downgraded CVRR to Sell, with a price target of $10.50, which represents a potential downside of 31% from where the stock is currently trading. Separately, on November 14, Barclays’ Paul Cheng upgraded the stock to Hold and has a price target of $14. In the last 30 days, insiders have sold $1.69M worth of CVRR shares.